Long-term disopyramide phosphate therapy effectively managed tachyarrhythmias in 60% of patients, with most tolerating side effects. However, 22% experienced recurrent symptoms, and 21% faced intolerable side effects within a year.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: